October 2, 1993European Heart Journal
-blockers or calcium antagonists in silent ischaemia?
Why the study?
Do anti-anginal agents reduce adverse outcomes in patients with silent myocardial ischaemia?
Population
Patients with coronary artery disease and unrecognized or silent myocardial ischaemia
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Should not yet change management of silent ischaemia; supports randomized trials of suppression.
Structured PICO
Do anti-anginal agents reduce adverse outcomes in patients with silent myocardial ischaemia?
P
Population
Patients with coronary artery disease and unrecognized or silent myocardial ischaemia
I
Intervention
Anti-anginal agents (e.g., nitrates, beta-blockers, calcium antagonists)
Silent myocardial ischaemia is a strong independent predictor of adverse outcomes in coronary artery disease, and its suppression with anti-anginal therapy may improve prognosis.
Cite This Study
Carl J. Pepine (1993) studied this question.